1. Capital expenditure to be incurred by our Subsidiary, OCT for expansion of the capacity of our cell manufacturing plantfrom 5 GWh to 6.4 GWh, classified as phase 2 under the expansion plan (the “Project”)
2. Repayment or pre-payment, in full or part, of the indebtedness incurred by our Subsidiary, OET
3. Investment into research and product development
4. Expenditure to be incurred for organic growth initiatives
and5. General corporate purposes.